Crown Marketing

CHAPEL HILL, NC -- (Marketwired) -- 04/24/13 -- Crown Marketing (OTCQB: CWNM) is pleased to announce that its subsidiary, Crown Nutraceuticals, Inc. will launch their first nutraceuticals and supplements product line anticipating sales to begin within the next thirty days. Crown's initial entrants into the market will be two popular ... read more

CHAPEL HILL, NC -- (Marketwire) -- 02/20/13 -- Crown Marketing (OTCQB: CWNM) is pleased to announce that patents for its Controlled Drug Delivery Technology (CDDT) have been approved and registered in Mexico. Mexico's pharmaceutical industry faces unique challenges. According to an American Enterprise Institute study, Mexico's $15.5 billion market is ... read more

CHAPEL HILL, NC -- (Marketwire) -- 02/14/13 -- Crown Marketing (OTCQB: CWNM) is pleased to announce that Patents for its Controlled Drug Delivery Technology have been approved and registered in South Africa. Crown is continuing to secure its worldwide patent rights as it pursues novel applications of its drug ... read more

CHAPEL HILL, NC -- (Marketwire) -- 02/07/13 -- Crown Marketing (OTCQB: CWNM) is pleased to announce that it has begun to review positive in vivo test results by examining blood plasma levels in test subjects using Crown's Controlled Drug Delivery Technology (CDDT). A clinical trial was conducted using 300 mg ... read more

CHAPEL HILL, NC -- (Marketwire) -- 02/05/13 -- Crown Marketing (OTCQB: CWNM) is pleased to announce that patents for its Controlled Drug Delivery Technology have been approved and registered in Norway. Crown is continuing to secure its worldwide patent rights as it pursues novel applications of its drug delivery ... read more

CHAPEL HILL, NC -- (Marketwire) -- 01/31/13 -- Crown Marketing (OTCQB: CWNM) is pleased to announce that it has achieved positive in-vitro testing results of the most widely prescribed Diabetes drug commonly known as Metformin. As the accompanying image indicates, Crown's Controlled Drug Delivery Device (CDDT) is less than ... read more

CHAPEL HILL, NC -- (Marketwire) -- 01/24/13 -- Crown Marketing (OTCQB: CWNM) is pleased to announce that it is in discussions to grant non-exclusive licenses of its Controlled Drug Delivery Technology (CDDT) to Nutraceutical and Supplement Companies. "It's a good fit with nutraceuticals in that it can increase the bio-availability ... read more

CHAPEL HILL, NC -- (Marketwire) -- 01/23/13 -- Crown Marketing (OTCQB: CWNM) is pleased to announce that its patent Counsel in India has filed a Statement regarding the working of the patented invention on a commercial scale in India in the matter of Patent No. 204009. Crown is committed to ... read more

CHAPEL HILL, NC -- (Marketwire) -- 01/17/13 -- Crown Marketing (OTCQB: CWNM) is pleased to announce its Japanese Patent application, Sustained Release Delivery Systems for Solutes, has been approved and registered. The intellectual property supporting the Controlled Drug Delivery Technology (CDDT) is comprehensively formulated to allow for the broad application ... read more

CHAPEL HILL, NC -- (Marketwire) -- 01/16/13 -- Crown Marketing (OTCQB: CWNM) is pleased to announce that Crown's Controlled Drug Delivery Technology (CDDT) will focus on utilizing its unique and novel controlled drug delivery device to assist pharmaceutical companies in their lifecycle management strategies to extend patent life for ... read more

CHAPEL HILL, NC -- (Marketwire) -- 12/19/12 -- Crown Marketing (OTCQB: CWNM) is pleased to announce that its Controlled Drug Delivery Technology (CDDT) has the potential to revolutionize the manner in which we take oral medication. Crown's CDDT is a novel controlled-release technology that harnesses the principles of diffusion through ... read more